Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01354106 · ClinicalTrials.gov registry record · NA
Adhesive Tape Trauma Evaluation of Two Gentle Tapes
A NA study of Adhesive Tape Trauma, sponsored by Solventum US.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT01354106: Completed NA study of Adhesive Tape Trauma, sponsored by Solventum US.
NCT01354106 is a NA study of Adhesive Tape Trauma that has completed, run by Solventum US. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01354106, a NA study of Adhesive Tape Trauma, has completed, sponsored by Solventum US.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine the relative gentleness of two tapes recognized for gentleness. A three-prong multidimensional evaluation consisting of laboratory assessments, expert skin grader and subject discomfort assessment will be used.
Primary Outcome
Expert grader using Erythema/Edema Scale 0=No visible response 1. mild response 2. moderate response 3. severe response 4. extreme response
Conditions Studied
Interventions
- DEVICE Skin Trauma
Study Locations (1)
Pennsylvania
- cyberDERM - Broomall
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2011-05 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT01354106 record still lists
NCT01354106 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Adhesive Tape Trauma appearing as the primary indexed condition, and to 1 intervention - of which Skin Trauma is the first listed.
NCT01354106 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01354106 about?
NCT01354106 is a clinical study titled "Adhesive Tape Trauma Evaluation of Two Gentle Tapes". The objective of this study is to determine the relative gentleness of two tapes recognized for gentleness. A three-prong multidimensional evaluation consisting of laboratory assessments, expert skin grader and subject discomfort assessment will be used.
What is the current status of trial NCT01354106?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2011-05. Estimated completion is 2011-06.
What conditions does trial NCT01354106 study?
This clinical trial studies the following conditions: Adhesive Tape Trauma.
What interventions are being tested in trial NCT01354106?
The interventions under investigation include: Skin Trauma (DEVICE).
Who is sponsoring clinical trial NCT01354106?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01354106 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01354106's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia